200_ The FDA Pathway for CBN: What It Means for Cannabis Supplements

Podcast: Innovating Cannabis Podcast · The Mary Jane Society

Opublikowano: 2026-07-03

Alleh Lindquist is the CEO and co-founder of FloraWorks, a cannabinoid innovation company focused on bringing science-backed minor cannabinoids into the mainstream. As a leading supplier of hemp-derived cannabinoids to manufacturers, FloraWorks has been at the forefront of CBN research and commercialization, including helping popularize CBN as an ingredient for sleep products. Today, the company's biggest focus is charting a regulatory pathway for CBN as a dietary supplement. After spending four years developing the safety data needed for FDA review, FloraWorks recently published peer-reviewed research supporting CBN's safety and has self-affirmed it as Generally Recognized As...